Fresh off its first FDA approval, Esperion gets green light for second non-statin cholesterol drug
The FDA approved Nexlizet, according to an entry in its database of approved drugs. The new drug combines the active ingredient of Nexletol - which the FDA approved last week - with a generic non-statin drug, ezetimibe.